國立虎尾科技大學 |

Public Regulation of Tumor Banks = Establishment, Heritage Status, Development and Sharing of Human Biological Samples /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Public Regulation of Tumor Banks/ edited by Xavier Bioy.
其他題名:	Establishment, Heritage Status, Development and Sharing of Human Biological Samples /
其他作者:	Bioy, Xavier.
面頁冊數:	XVI, 223 p. 13 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Private international law. -
電子資源:	https://doi.org/10.1007/978-3-319-90563-1
ISBN:	9783319905631

Public Regulation of Tumor Banks = Establishment, Heritage Status, Development and Sharing of Human Biological Samples /
Public Regulation of Tumor BanksEstablishment, Heritage Status, Development and Sharing of Human Biological Samples /[electronic resource] :edited by Xavier Bioy. - 1st ed. 2018. - XVI, 223 p. 13 illus. in color.online resource.

Part I – Tumor Banks or the Valorisation of a Complex Object: 1 Is Putting Cancer in Banks a Patrimony to be Developed? by Xavier Bioy -- 2 Biological Samples and Their Sampling Degrees by Thibaut Coussens-Barre -- 3 The Protection of Personal Data by Emilie Debaets -- 4 The Policies of Tumour Biobankers: Main Strategies and an Example of the Policies Adopted by the Nice Hospital Biobank, France by Paul Hofman -- 5 The Concept of Biological Samples Collection by Anne Brouchet and Sophie Peries -- 6 Does Tumour Bank Regulation Promote the Valorisation of Tumour Collections? by Anna Pigeon -- 7 Economic Modeling and Valorisation of Biobanks by Catherine Bobtcheff and Carole Haritchabalet -- 8 Socializing Tumours – From the Conservation of Tumours in Banks to Their Ontological Variations by Fabien Milanovic -- Part II – The Issues Related to Tumour Collections Valorisation: 9 The Valorisation of Tumour Collections: Reconciling the Interests of the Different Actors by Emmanuelle Rial-Sebbag.-10 The Development of Tumour Collections: The Interest of the European Union by Nathalie De Grove-Valdeyron -- Part III – The Means for Tumour Collections Valorisation: 11 Academic Valorisation of Biobanks by Anne-Marie Duguet, Laurence Mabile and Anne Cambon-Thomsen -- 12 Marketing through the Use of Private Law Contracts by Laurent Izac -- 13 The Governance Framework of North American Biobanks: A Rapidly Evolving Policy Patchwork by Miriam Pinkesz and Yann Joly -- 14 Biobank Expertise and the Research Unit-biobank Relationship by Catherine Bobtcheff and Carole Haritchabalet -- 15 Extra-patrimoniality for the Patient by Sophie Paricard -- 16 The Moment of Patrimonialization by Marie-Xavière Catto -- 17 The Patrimonial Specificities of Public Persons by Benoît Schmaltz and Pierre Égéa -- 18 Biological Sample Collection in the Era of Genomic Medicine: A New Example of a Public Commons? by Christine Noiville and Florence Bellivier.

The multidisciplinary book assesses the legal and economic uncertainties surrounding the collection, storage, provision and economic development of biological samples (tumors, tissues, cells) and associated personal data related to oncology. Public, partly public and private sector actors in the field of cancer care and research hold collections supported by significant public and social funding. Under certain conditions, particularly in the context of networking (sometimes promoted by public authorities), these collections can also represent major economic assets and scientific resources. However, this involves a number of issues and institutional constraints: legal: the will of the source person; non-pecuniary damage; freedom to establish collections; competence in deciding on their use; legal frameworks for their distribution; desire for return on investment for public institutions, notably in terms of industrial and intellectual property. economic: cost of establishing and running biological resource centres; destroying resources; emerging markets; profit sharing. public health policy choices: prioritisation of therapeutic measures over research (fundamental or clinical trials); conservation of resources; promotion of scientific (and not commercial) value of collections. The establishment, heritage recognition (“patrimonialisation”), development and sharing of these resources thus merit our calling into question present practices and their evolution, as well as the leverage available to public authorities (incentives, legislation, regulation) in a context where norms emerge from professional practice to become widely used in collaborative networks. Filling a gap in the current literature on law and economics, which pays little heed to these specific considerations, this book explores these considerations to bring to light the economic implications of ethical choices and governance issues in the health sector (structural organisation of local, national and European actors in oncology). It is intended for researchers in fields such as law, economics and biomedical sciences, as well as for public policymakers.

ISBN: 9783319905631

Standard No.: 10.1007/978-3-319-90563-1doiSubjects--Topical Terms:

1202562
Private international law.

LC Class. No.: K7000-7720.22

Dewey Class. No.: 340.9

Public Regulation of Tumor Banks = Establishment, Heritage Status, Development and Sharing of Human Biological Samples /
LDR:05598nam a22004335i 4500 001 997500
003 DE-He213
005 20200703075836.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319905631 $9 978-3-319-90563-1
024 7 $a 10.1007/978-3-319-90563-1 $2 doi
035 $a 978-3-319-90563-1
050 4 $a K7000-7720.22
050 4 $a K7073-7078
072 7 $a LB $2 bicssc
072 7 $a LAW051000 $2 bisacsh
072 7 $a LB $2 thema
072 7 $a LAM $2 thema
082 0 4 $a 340.9 $2 23
082 0 4 $a 340.2 $2 23
245 1 0 $a Public Regulation of Tumor Banks $h [electronic resource] : $b Establishment, Heritage Status, Development and Sharing of Human Biological Samples / $c edited by Xavier Bioy.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a XVI, 223 p. 13 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Part I – Tumor Banks or the Valorisation of a Complex Object: 1 Is Putting Cancer in Banks a Patrimony to be Developed? by Xavier Bioy -- 2 Biological Samples and Their Sampling Degrees by Thibaut Coussens-Barre -- 3 The Protection of Personal Data by Emilie Debaets -- 4 The Policies of Tumour Biobankers: Main Strategies and an Example of the Policies Adopted by the Nice Hospital Biobank, France by Paul Hofman -- 5 The Concept of Biological Samples Collection by Anne Brouchet and Sophie Peries -- 6 Does Tumour Bank Regulation Promote the Valorisation of Tumour Collections? by Anna Pigeon -- 7 Economic Modeling and Valorisation of Biobanks by Catherine Bobtcheff and Carole Haritchabalet -- 8 Socializing Tumours – From the Conservation of Tumours in Banks to Their Ontological Variations by Fabien Milanovic -- Part II – The Issues Related to Tumour Collections Valorisation: 9 The Valorisation of Tumour Collections: Reconciling the Interests of the Different Actors by Emmanuelle Rial-Sebbag.-10 The Development of Tumour Collections: The Interest of the European Union by Nathalie De Grove-Valdeyron -- Part III – The Means for Tumour Collections Valorisation: 11 Academic Valorisation of Biobanks by Anne-Marie Duguet, Laurence Mabile and Anne Cambon-Thomsen -- 12 Marketing through the Use of Private Law Contracts by Laurent Izac -- 13 The Governance Framework of North American Biobanks: A Rapidly Evolving Policy Patchwork by Miriam Pinkesz and Yann Joly -- 14 Biobank Expertise and the Research Unit-biobank Relationship by Catherine Bobtcheff and Carole Haritchabalet -- 15 Extra-patrimoniality for the Patient by Sophie Paricard -- 16 The Moment of Patrimonialization by Marie-Xavière Catto -- 17 The Patrimonial Specificities of Public Persons by Benoît Schmaltz and Pierre Égéa -- 18 Biological Sample Collection in the Era of Genomic Medicine: A New Example of a Public Commons? by Christine Noiville and Florence Bellivier.
520 $a The multidisciplinary book assesses the legal and economic uncertainties surrounding the collection, storage, provision and economic development of biological samples (tumors, tissues, cells) and associated personal data related to oncology. Public, partly public and private sector actors in the field of cancer care and research hold collections supported by significant public and social funding. Under certain conditions, particularly in the context of networking (sometimes promoted by public authorities), these collections can also represent major economic assets and scientific resources. However, this involves a number of issues and institutional constraints: legal: the will of the source person; non-pecuniary damage; freedom to establish collections; competence in deciding on their use; legal frameworks for their distribution; desire for return on investment for public institutions, notably in terms of industrial and intellectual property. economic: cost of establishing and running biological resource centres; destroying resources; emerging markets; profit sharing. public health policy choices: prioritisation of therapeutic measures over research (fundamental or clinical trials); conservation of resources; promotion of scientific (and not commercial) value of collections. The establishment, heritage recognition (“patrimonialisation”), development and sharing of these resources thus merit our calling into question present practices and their evolution, as well as the leverage available to public authorities (incentives, legislation, regulation) in a context where norms emerge from professional practice to become widely used in collaborative networks. Filling a gap in the current literature on law and economics, which pays little heed to these specific considerations, this book explores these considerations to bring to light the economic implications of ethical choices and governance issues in the health sector (structural organisation of local, national and European actors in oncology). It is intended for researchers in fields such as law, economics and biomedical sciences, as well as for public policymakers.
650 0 $a Private international law. $3 1202562
650 0 $a Conflict of laws. $3 560163
650 0 $a Cancer research. $3 1253664
650 0 $a Health economics. $2 bicssc $3 810102
650 0 $a Law—Europe. $3 1254279
650 0 $a Medical ethics. $3 559096
650 0 $a Oncology . $3 1253469
650 1 4 $a Private International Law, International & Foreign Law, Comparative Law . $3 1209897
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Health Economics. $3 786205
650 2 4 $a European Law. $3 883672
650 2 4 $a Theory of Medicine/Bioethics. $3 671734
650 2 4 $a Oncology. $3 593951
700 1 $a Bioy, Xavier. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1206301
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319905624
776 0 8 $i Printed edition: $z 9783319905648
776 0 8 $i Printed edition: $z 9783030080433
856 4 0 $u https://doi.org/10.1007/978-3-319-90563-1
912 $a ZDB-2-LCR
912 $a ZDB-2-SXLC
950 $a Law and Criminology (SpringerNature-41177)
950 $a Law and Criminology (R0) (SpringerNature-43727)